HIV-infected injection drug users (IDUs) represent a marginalized population with substantial disparities in health care access and outcomes. Since 1988, the AIDS Linked to the Intravenous Experience (ALIVE) study has followed disadvantaged, predominantly African American HIV-infected and at-risk IDUs in a community-based observational cohort, providing important evidence on the natural and treated course of HIV among IDUs. We have characterized the rates and risk factors for incident HIV infection and for progression to AIDS or death, described patterns of risk behavior, and determined barriers to optimal HIV care. Since availability of effective antiretroviral therapy (ART), optimal HIV care is now achieved by early HIV testing;prompt linkage to HIV care, timely initiation of ART, high adherence, retention in care, and prolonged virological suppression. Drug use may have detrimental effects at each stage of this HIV Care Continuum. Proposed is a multidisciplinary research agenda with the primary objective to continue the epidemiological, pathogenesis, behavioral, and clinical characterization of the evolving HIV epidemic among IDUs as they age and drug use patterns change. While the cohort has and continues to be a platform for an array of studies critical to addressing critical on HIV and drug use, this proposal emphasizes examination of IDUs'navigation of the HIV Care Continuum.
We aim to characterize the dynamic nature of the Care Continuum and to identify the key determinants of successful navigation and the consequences of stagnation. Successful navigation entails consistent engagement in care with prompt ART initiation and prolonged viral suppression. In contrast, we introduce the concept of stagnation, incorporating navigation patterns involving a failure to progress and delayed or relapsing transitions through the Continuum. We will describe longitudinal navigation patterns, characterize the time required to transition through stages, and identify sociodemographic, behavioral, provider and neighborhood-level determinants of the primary navigation patterns. We hypothesize that less successful navigation (stagnation) in the Care Continuum will have serious clinical consequences, increasing the risk for both AIDS or non-AIDS events as well as death. The key impact of this aim is to illuminate mechanisms, identify modifiable risk factors, and provide novel insight to inform efficient and targeted intervention development to mitigate the consequences of less effective HIV care among IDUs. To achieve these aims, we continue biannual visits with interview, exam, and biospecimen collection supplemented by medical record review and registry linkage. ALIVE represents the minority, socially-marginalized population at highest risk for HIV progression and limited access to care in Baltimore and nationally. The ALIVE study remains well- positioned to address these emerging issues confronting aging HIV-infected IDUs, namely characterizing long- term outcomes and enhancing HIV care through improving navigation of the HIV Care Continuum.

Public Health Relevance

This proposal supports continuation of the AIDS Linked to the Intravenous Experience (ALIVE) study which has followed disadvantaged, predominantly African American HIV-infected and at-risk injection drug users (IDUs) in a community-based cohort since 1988. ALIVE provides a platform for longitudinally measuring risk behavior, treatment outcomes, disease incidence and prevalence, and cause-specific mortality among aging HIV-infected IDUs while also supporting independently-funded investigations of HIV and drug use. Focusing on how IDUs'navigate the HIV Care Continuum, we aim to understand mechanisms, identify modifiable risk factors, and inform intervention development to improve the effectiveness of HIV care among IDUs.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-NXR-B (15))
Program Officer
Lambert, Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Public Health & Prev Medicine
Schools of Public Health
United States
Zip Code
Stone, Jack; Fraser, Hannah; Lim, Aaron G et al. (2018) Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis 18:1397-1409
Smith, M K; Graham, M; Latkin, C A et al. (2018) Quantifying potentially infectious sharing patterns among people who inject drugs in Baltimore, USA. Epidemiol Infect 146:1845-1853
Anagnostopoulos, Alexia; Abraham, Alison G; Genberg, Becky L et al. (2018) Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore. Addict Behav 81:39-45
Boelen, Lies; Debebe, Bisrat; Silveira, Marcos et al. (2018) Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. Sci Immunol 3:
McCarthy, Elisa K; Vakos, Amanda; Cottagiri, Merylin et al. (2018) Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis. mSphere 3:
Drummond, M Bradley; Lambert, Allison A; Hussien, Amira F et al. (2017) HIV Infection Is Independently Associated with Increased CT Scan Lung Density. Acad Radiol 24:137-145
Vergara, C; Thio, C; Latanich, R et al. (2017) Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun 18:82-87
Dubrow, Robert; Qin, Li; Lin, Haiqun et al. (2017) Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr 75:382-390
Piggott, Damani A; Muzaale, Abimereki D; Varadhan, Ravi et al. (2017) Frailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci 72:389-394
Veenhuis, Rebecca T; Astemborski, Jacquie; Chattergoon, Michael A et al. (2017) Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection. Clin Infect Dis 64:589-596

Showing the most recent 10 out of 94 publications